{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:24Z","timestamp":1792784184188,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Genoma Espa\u00f1a"},{"DOI":"10.13039\/100011708","name":"SMA Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["260862"],"award-info":[{"award-number":["260862"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC NC3Rs","award":["NC\/L001780\/1"],"award-info":[{"award-number":["NC\/L001780\/1"]}]},{"DOI":"10.13039\/501100007155","name":"MRC","doi-asserted-by":"publisher","award":["MR\/P026494\/1"],"award-info":[{"award-number":["MR\/P026494\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"MRC","doi-asserted-by":"publisher","award":["MR\/N026101\/1"],"award-info":[{"award-number":["MR\/N026101\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"MRC","doi-asserted-by":"publisher","award":["MR\/019075\/1"],"award-info":[{"award-number":["MR\/019075\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jconrel.2017.12.029","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T13:12:58Z","timestamp":1514466778000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors"],"prefix":"10.1016","volume":"273","author":[{"given":"Sherif G.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela","family":"Boza-Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Y\u00e1\u00f1ez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.12.029_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/JVI.01865-08","article-title":"Insertional gene activation by lentiviral and gammaretroviral vectors","volume":"83","author":"Bokhoven","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0025","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1358\/dnp.2003.16.5.829314","article-title":"Gene transfer in experimental medicine","volume":"16","author":"Romano","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1358\/dnp.2005.18.2.886481","article-title":"Current development of lentiviral-mediated gene transfer","volume":"18","author":"Romano","year":"2005","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0040","first-page":"424","article-title":"Human immunodeficiency virus type 1 (HIV-1) derived vectors: safety considerations and controversy over therapeutic applications","volume":"13","author":"Romano","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/hum.2010.119","article-title":"Correction of SCID-X1 using an enhancerless Vav promoter","volume":"22","author":"Almarza","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/hum.2009.141","article-title":"Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia","volume":"21","author":"Gonzalez-Murillo","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0055","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.1128\/JVI.00485-12","article-title":"Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing","volume":"86","author":"Knight","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0060","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2006-12-060814","article-title":"Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0070","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2009-10-250209","article-title":"A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0065-3527(08)60309-7","article-title":"In vivo analysis of retroviral integrase structure and function","volume":"52","author":"Engelman","year":"1999","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0075","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2009.122","article-title":"Integration-deficient lentiviral vectors: a slow coming of age","volume":"17","author":"Wanisch","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","article-title":"Effective gene therapy with nonintegrating lentiviral vectors","volume":"12","author":"Y\u00e1\u00f1ez-Mu\u00f1oz","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0085","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo","volume":"103","author":"Philippe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/gt.2008.186","article-title":"Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors","volume":"16","author":"Rahim","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/gt.2012.78","article-title":"Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord","volume":"20","author":"Peluffo","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/hum.2014.003","article-title":"Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease","volume":"25","author":"Lu-Nguyen","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0105","first-page":"9","article-title":"Candidate diseases for prenatal gene therapy","volume":"891","author":"David","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0110","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.gt.3302632","article-title":"Gene therapy progress and prospects: fetal gene therapy\u2014first proofs of concept\u2014some adverse effects","volume":"12","author":"Coutelle","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ymthe.2005.01.015","article-title":"In utero gene therapy: current challenges and perspectives","volume":"11","author":"Waddington","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0120","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood-2002-03-0779","article-title":"In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor","volume":"101","author":"Waddington","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/10430340252898984","article-title":"High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter","volume":"13","author":"Demaison","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/76095","article-title":"Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences","volume":"25","author":"Follenzi","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0135","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/87979","article-title":"A quantitative assay for HIV DNA integration in vivo","volume":"7","author":"Butler","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0145","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nprot.2006.207","article-title":"Production and characterization of adeno-associated viral vectors","volume":"1","author":"Grieger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0150","first-page":"107","article-title":"In utero gene therapy","volume":"2","author":"Larson","year":"2000","journal-title":"Ochsner J"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymthe.2003.11.013","article-title":"In utero gene therapy rescues vision in a murine model of congenital blindness","volume":"9","author":"Dejneka","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0160","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2011-09-377630","article-title":"AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage","volume":"119","author":"Binny","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0165","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aah6192","article-title":"Lentiviral vectors, two decades later","volume":"353","author":"Naldini","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0170","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1042\/BST0381489","article-title":"In utero gene transfer to the mouse nervous system","volume":"38","author":"Rahim","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1006\/mthe.2002.0584","article-title":"Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins","volume":"5","author":"Watson","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0180","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nmeth.1514","article-title":"Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors","volume":"7","author":"Anliker","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0185","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tibtech.2015.09.008","article-title":"Surface-engineered viral vectors for selective and cell type-specific gene delivery","volume":"33","author":"Buchholz","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0190","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.gt.3302924","article-title":"Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters","volume":"14","author":"Hioki","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0195","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jnr.10719","article-title":"Targeted transgene expression in rat brain using lentiviral vectors","volume":"73","author":"Jakobsson","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0200","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/nbt1372","article-title":"Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state","volume":"25","author":"Brown","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/glia.20795","article-title":"Engineered lentiviral vector targeting astrocytes in vivo","volume":"57","author":"Colin","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2017.12.029_bb0210","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1038\/mtm.2016.46","article-title":"Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs","volume":"3","author":"Miyanohara","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0220","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1128\/MCB.26.10.3764-3772.2006","article-title":"Cortical thinning and hydrocephalus in mice lacking the immunoglobulin superfamily member CDO","volume":"26","author":"Zhang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0225","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nbt0909-804","article-title":"The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9","volume":"27","author":"Saunders","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.12.029_bb0230","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T20:52:51Z","timestamp":1603572771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917310994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":46,"alternative-id":["S0168365917310994"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}